Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.48 USD | -7.20% | +13.33% | +11.64% |
05-17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
05-17 | Deutsche Bank Adjusts GoodRx Price Target to $9 From $8, Maintains Hold Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.64% | 2.81B | |
+27.57% | 268B | |
+6.66% | 137B | |
+32.61% | 96.13B | |
+6.99% | 92.47B | |
+61.15% | 60.06B | |
+18.75% | 48.02B | |
+24.94% | 37.9B | |
+0.13% | 35.73B | |
+15.50% | 29.23B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Transcript : GoodRx Holdings, Inc., Q3 2023 Earnings Call, Nov 09, 2023